Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 01/24/2025 | 12.34 M | $171.89 M | 5.80% | 9.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 11.40 M | $158.79 M | 6.32% | 9.17% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 10.97 M | $152.77 M | 0.00% | 8.82% |
| BLACKROCK, INC. | 02/07/2025 | 9.15 M | $127.44 M | 1.32% | 7.36% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 8.79 M | $122.38 M | 0.00% | 7.07% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 7.38 M | $102.77 M | 7.16% | 5.94% |
| VANGUARD GROUP INC | 02/11/2025 | 6.44 M | $89.72 M | -7.50% | 5.18% |
| STATE STREET CORP | 02/14/2025 | 4.95 M | $68.96 M | -12.25% | 3.98% |
| MORGAN STANLEY | 02/14/2025 | 4.24 M | $59.12 M | 12.24% | 3.41% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 3.90 M | $54.37 M | 9.82% | 3.14% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 3.31 M | $46.10 M | -22.14% | 2.66% |
| UBS GROUP AG | 02/14/2025 | 2.79 M | $38.86 M | 1,166.85% | 2.24% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 2.51 M | $35.01 M | 44.04% | 2.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.47 M | $34.45 M | 0.10% | 1.99% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 2.37 M | $33.07 M | -1.77% | 1.91% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.31 M | $32.18 M | 101.33% | 1.86% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2025 | 2.12 M | $29.54 M | 0.00% | 1.71% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 1.83 M | $25.42 M | -21.51% | 1.47% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.75 M | $24.43 M | 617.52% | 1.41% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 1.63 M | $22.72 M | 11.40% | 1.31% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 1.58 M | $580.63 K | 530.00% | 1.27% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 1.54 M | $21.51 M | -3.11% | 1.24% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.31 M | $18.19 M | -17.85% | 1.05% |
| CERCANO MANAGEMENT LLC | 02/14/2025 | 1.26 M | $17.49 M | 100.00% | 1.01% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.14 M | $15.90 M | -11.98% | 0.92% |
| INVESCO LTD. | 02/13/2025 | 1.13 M | $15.69 M | 20.05% | 0.91% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.10 M | $15.28 M | 100.00% | 0.88% |
| CANDRIAM S.C.A. | 02/07/2025 | 1.04 M | $14.52 M | -26.94% | 0.84% |
| NORTHERN TRUST CORP | 02/14/2025 | 991.06 K | $13.81 M | 5.82% | 0.80% |
| TEJARA CAPITAL LTD | 02/10/2025 | 886.84 K | $12.35 M | -23.90% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 878.80 K | $12.24 M | 2.20% | 0.71% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 742.30 K | $10.34 M | 100.00% | 0.60% |
| J. GOLDMAN & CO LP | 02/14/2025 | 612.64 K | $8.53 M | -58.94% | 0.49% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 592.57 K | $8.25 M | 3.48% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 536.46 K | $7.47 M | -54.38% | 0.43% |
| FISHMAN JAY A LTD/MI | 01/29/2025 | 536.40 K | $7.47 M | 28.33% | 0.43% |
| NORGES BANK | 02/12/2025 | 532.79 K | $7.42 M | 100.00% | 0.43% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 500.97 K | $6.98 M | -71.83% | 0.40% |
| FEDERATED HERMES, INC. | 02/13/2025 | 492.92 K | $6.87 M | -1.78% | 0.40% |
| ABRDN PLC | 01/24/2025 | 482.07 K | $6.72 M | 0.00% | 0.39% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 388.31 K | $5.41 M | -51.65% | 0.31% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 387.54 K | $5.40 M | -51.56% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 366.89 K | $5.11 M | -54.57% | 0.30% |
| CITIGROUP INC | 02/12/2025 | 327.27 K | $4.56 M | 265.16% | 0.26% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 325.71 K | $4.54 M | 100.00% | 0.26% |
| PDT PARTNERS, LLC | 02/14/2025 | 319.72 K | $4.45 M | 0.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 305.01 K | $4.25 M | -1.95% | 0.25% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 290.94 K | $4.05 M | 126.51% | 0.23% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 280.10 K | $3.90 M | 1.23% | 0.23% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 263.14 K | $3.67 M | 100.00% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcutis Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC: 0
Venturi Wealth Management, LLC: 0
Tradewinds, LLC.: 0
FIRST UNITED BANK & TRUST: 0
SUVRETTA CAPITAL MANAGEMENT, LLC: 11.4 M
Rubric Capital Management LP: 10.97 M
103.65% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 114.37 M shares in the last 24 months. This purchase volume represents approximately $1.57 B in transactions.